优化药物研发的临床试验模拟发展、应用及思考  

Development,applications,and considerations of clinical trialsimulation that optimizes drug discovery

作　　者：王思村 刘骏[1] 陈亚飞 王忠[1] 于亚南[1] WANG Si-cun;LIU Jun;CHEN Ya-fei;WANG Zhong;YU Ya-nan(Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China)

机构地区：[1]中国中医科学院中医临床基础医学研究所,北京100700

出　　处：《中国新药杂志》2024年第9期917-923,共7页Chinese Journal of New Drugs

基　　金：中国中医科学院科技创新工程项目(CI2021A04707);国家自然科学基金项目(82105052)。

摘　　要：现代制药行业正在从传统方法向人工智能等先进技术过渡,不断将建模和模拟纳入药物发现、开发、设计和优化。在药物临床试验背景下,临床试验模拟(clinical trial simulation, CTS)技术综合相关信息,在药物研发的各个阶段发挥作用,已成为支持决策制定和减少临床试验失败的有用工具,得到医药企业和监管部门的广泛认可。本文参考国内外相关最新文献和指导原则,梳理临床试验模拟的发展历程、核心方法、应用范围等,旨在帮助研究者更好地认识和理解该技术在药物研究,尤其是新药研发领域的应用及价值,提高决策质量、效率和成本效益。The modern pharmaceutical industry is transitioning from using traditional methods to advanced technologies like artificial intelligence,constantly incorporating modeling and simulation into drug discovery,development,design and optimization.In the context of drug clinical trials,clinical trial simulation(CTS)integrates relevant information and plays an important role in various stages of drug development.It has become a helpful tool to support decision-making and reduce failure occurrence of clinical trials,and has been widely recognized by pharmaceutical companies and regulatory authorities.By referring to the latest literature and guidelines from domestic and overseas,we reviewed the history,core methods and application range of CTS,aiming to help researchers better understand the application and value of this technology in drug research,especially new drug discovery.Hopefully,it can help improve the quality and efficiency of decision-making and increase cost-effectiveness.

关 键 词：临床试验模拟 模型引导的药物研发 建模和模拟 

分 类 号：R95[医药卫生—药学]